Health Catalyst Company Insiders
HCAT Stock | USD 4.33 0.18 3.99% |
Health Catalyst's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Health Catalyst suggests that vertually all insiders are panicking. Health Catalyst employs about 1.5 K people. The company is managed by 23 executives with a total tenure of roughly 3500 years, averaging almost 152.0 years of service per executive, having 65.22 employees per reported executive.
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
2025-03-06 | Benjamin Landry | Disposed 13827 @ 4.55 | View | ||
2025-03-05 | Daniel Lesueur | Disposed 16902 @ 4.52 | View | ||
2025-02-18 | Linda Llewelyn | Disposed 6441 @ 5.43 | View | ||
2025-02-05 | Daniel Lesueur | Disposed 5209 @ 5.76 | View | ||
2025-01-15 | Linda Llewelyn | Disposed 6442 @ 5.8 | View | ||
2025-01-06 | Daniel Lesueur | Disposed 5209 @ 7.51 | View | ||
2024-12-30 | Duncan Gallagher | Disposed 4500 @ 6.93 | View | ||
2024-12-23 | Duncan Gallagher | Disposed 4500 @ 6.98 | View | ||
2024-12-16 | Linda Llewelyn | Disposed 6442 @ 7.88 | View | ||
2024-12-06 | Benjamin Landry | Disposed 19268 @ 8.32 | View | ||
2024-12-02 | Kevin Lee Freeman | Disposed 7500 @ 8.94 | View | ||
2024-11-05 | Daniel Lesueur | Disposed 5209 @ 7.7 | View | ||
2024-10-15 | Linda Llewelyn | Disposed 1324 @ 8.16 | View | ||
2024-10-03 | Daniel Lesueur | Disposed 5209 @ 7.68 | View | ||
2024-09-16 | Linda Llewelyn | Disposed 1324 @ 8.43 | View | ||
2024-09-06 | Jason Alger | Disposed 2899 @ 7.39 | View | ||
2024-09-04 | Daniel Lesueur | Disposed 8137 @ 7.58 | View |
Monitoring Health Catalyst's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Health |
Health Catalyst Management Team Effectiveness
The company has return on total asset (ROA) of (0.0457) % which means that it has lost $0.0457 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1899) %, meaning that it created substantial loss on money invested by shareholders. Health Catalyst's management efficiency ratios could be used to measure how well Health Catalyst manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.14 in 2025. Return On Capital Employed is likely to drop to -0.14 in 2025. At this time, Health Catalyst's Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 192.5 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 583.9 M in 2025.Common Stock Shares Outstanding is likely to drop to about 45.6 M in 2025. Net Loss is likely to drop to about (129.8 M) in 2025
Health Catalyst Workforce Comparison
Health Catalyst is rated # 5 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 22,622. Health Catalyst holds roughly 1,500 in number of employees claiming about 7% of equities under Health Care industry.
Health Catalyst Profit Margins
The company has Profit Margin (PM) of (0.23) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.19) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.19.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.38 | 0.4592 |
|
|
Health Catalyst Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Health Catalyst insiders, such as employees or executives, is commonly permitted as long as it does not rely on Health Catalyst's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Health Catalyst insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2025-03-01 | 1.2727 | 14 | 11 | 1,076,260 | 103,363 |
2024-12-01 | 0.2353 | 4 | 17 | 33,170 | 175,452 |
2024-09-01 | 0.2 | 3 | 15 | 6,592 | 48,068 |
2024-06-01 | 0.3571 | 5 | 14 | 104,035 | 56,091 |
2024-03-01 | 0.8 | 12 | 15 | 691,756 | 42,134 |
2023-12-01 | 0.0909 | 1 | 11 | 20,000 | 47,754 |
2023-06-01 | 0.8824 | 15 | 17 | 216,594 | 21,926 |
2023-03-01 | 0.5714 | 8 | 14 | 254,225 | 82,075 |
2022-12-01 | 0.0909 | 1 | 11 | 197,078 | 61,795 |
2022-09-01 | 0.3846 | 5 | 13 | 402,272 | 24,121 |
2022-06-01 | 0.4 | 12 | 30 | 170,258 | 210,514 |
2022-03-01 | 0.6818 | 30 | 44 | 635,791 | 150,213 |
2021-12-01 | 0.3291 | 26 | 79 | 138,559 | 322,790 |
2021-09-01 | 0.3833 | 23 | 60 | 140,916 | 312,750 |
2021-06-01 | 0.4194 | 26 | 62 | 276,582 | 577,621 |
2021-03-01 | 0.3462 | 27 | 78 | 460,864 | 283,860 |
2020-12-01 | 0.3467 | 26 | 75 | 198,840 | 484,906 |
2020-09-01 | 0.43 | 43 | 100 | 1,030,085 | 4,462,146 |
2020-06-01 | 0.807 | 46 | 57 | 524,096 | 801,503 |
2020-03-01 | 0.8148 | 22 | 27 | 548,873 | 6,201,309 |
2019-12-01 | 1.0 | 1 | 1 | 1,150 | 1,150 |
2019-09-01 | 0.3143 | 22 | 70 | 20,339,076 | 16,902,962 |
Health Catalyst Notable Stakeholders
A Health Catalyst stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Health Catalyst often face trade-offs trying to please all of them. Health Catalyst's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Health Catalyst's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
T Elbert | Chief VP | Profile | |
Maxine Liu | Senior Interopability | Profile | |
Holly Rimmasch | Senior Officer | Profile | |
Kevin Freeman | Chief Officer | Profile | |
Paul Horstmeier | Chief Officer | Profile | |
Tarah Bryan | Chief Officer | Profile | |
Ryan Barry | Chief Services | Profile | |
Kyle Salyers | Chief Development | Profile | |
Adam Brown | Senior Analysis | Profile | |
Kevin Scharnhorst | Chief Officer | Profile | |
Jeffrey Selander | Senior International | Profile | |
Leslie Falk | Chief Officer | Profile | |
Daniel LeSueur | Chief Officer | Profile | |
Jason Jones | Chief Platform | Profile | |
Benjamin Landry | General Board | Profile | |
Bryan Hunt | Senior Advisor | Profile | |
Linda Llewelyn | Chief Officer | Profile | |
Amanda Flanders | Senior Communications | Profile | |
Dave Ross | Chief Officer | Profile | |
Daniel Burton | CEO Director | Profile | |
Daniel Orenstein | Senior Advisor | Profile | |
Patrick Nelli | Advisor | Profile | |
Jason Alger | Chief Officer | Profile |
About Health Catalyst Management Performance
The success or failure of an entity such as Health Catalyst often depends on how effective the management is. Health Catalyst management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Health management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Health management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.14) | (0.14) | |
Return On Capital Employed | (0.13) | (0.14) | |
Return On Assets | (0.08) | (0.08) | |
Return On Equity | (0.19) | (0.20) |
Please note, the imprecision that can be found in Health Catalyst's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Health Catalyst. Check Health Catalyst's Beneish M Score to see the likelihood of Health Catalyst's management manipulating its earnings.
Health Catalyst Workforce Analysis
Traditionally, organizations such as Health Catalyst use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Health Catalyst within its industry.Health Catalyst Manpower Efficiency
Return on Health Catalyst Manpower
Revenue Per Employee | 204.4K | |
Revenue Per Executive | 13.3M | |
Net Loss Per Employee | 46.3K | |
Net Loss Per Executive | 3M | |
Working Capital Per Employee | 93.2K | |
Working Capital Per Executive | 6.1M |
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.